- Report
- April 2022
- 307 Pages
Global
From €5333EUR$5,550USD£4,585GBP
- Book
- April 2023
- 128 Pages
- Book
- November 2019
- 432 Pages
- Book
- November 2019
- 432 Pages
- Book
- April 2024
- 448 Pages
- Book
- September 2021
- 304 Pages
- Book
- January 2019
- 264 Pages
- Book
- March 2018
- 112 Pages
- Book
- January 2017
- 488 Pages
- Book
- January 2016
- 952 Pages
- Book
- April 2013
- 256 Pages
- Book
- November 2012
- 240 Pages
- Book
- November 2010
- 232 Pages
- Book
- May 2019
North America
The Platelet Disorder market is a subset of the Hematology market, which focuses on the study of blood and blood-forming organs. Platelet Disorders are a group of conditions that affect the production, function, and lifespan of platelets, which are a type of blood cell responsible for clotting. Platelet Disorders can be caused by a variety of factors, including genetic mutations, autoimmune diseases, and certain medications. Symptoms of Platelet Disorders can range from mild to severe, and can include excessive bleeding, bruising, and fatigue. Treatment options for Platelet Disorders vary depending on the cause and severity of the condition, and may include medications, lifestyle changes, and blood transfusions.
Companies in the Platelet Disorder market include Novartis, Pfizer, Bayer, and Shire. Show Less Read more